- Home
- FRO vs BLCO Comparison
FRO vs BLCO Comparison
Compare FRO & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRO
- BLCO
- Stock Information
- Founded
- FRO 1985
- BLCO 1853
- Country
- FRO Cyprus
- BLCO Canada
- Employees
- FRO N/A
- BLCO N/A
- Industry
- FRO Marine Transportation
- BLCO Ophthalmic Goods
- Sector
- FRO Consumer Discretionary
- BLCO Health Care
- Exchange
- FRO Nasdaq
- BLCO Nasdaq
- Market Cap
- FRO 4.5B
- BLCO 4.9B
- IPO Year
- FRO N/A
- BLCO 2022
- Fundamental
- Price
- FRO $23.66
- BLCO $14.89
- Analyst Decision
- FRO Strong Buy
- BLCO Hold
- Analyst Count
- FRO 3
- BLCO 11
- Target Price
- FRO $25.00
- BLCO $15.80
- AVG Volume (30 Days)
- FRO 2.7M
- BLCO 512.5K
- Earning Date
- FRO 08-29-2025
- BLCO 10-29-2025
- Dividend Yield
- FRO 7.53%
- BLCO N/A
- EPS Growth
- FRO N/A
- BLCO N/A
- EPS
- FRO 1.07
- BLCO N/A
- Revenue
- FRO $1,823,905,000.00
- BLCO $4,891,000,000.00
- Revenue This Year
- FRO N/A
- BLCO $8.27
- Revenue Next Year
- FRO $14.48
- BLCO $5.73
- P/E Ratio
- FRO $22.44
- BLCO N/A
- Revenue Growth
- FRO N/A
- BLCO 8.81
- 52 Week Low
- FRO $12.40
- BLCO $10.45
- 52 Week High
- FRO $25.68
- BLCO $21.69
- Technical
- Relative Strength Index (RSI)
- FRO 72.58
- BLCO 53.33
- Support Level
- FRO $22.31
- BLCO $15.00
- Resistance Level
- FRO $24.21
- BLCO $15.50
- Average True Range (ATR)
- FRO 0.55
- BLCO 0.35
- MACD
- FRO 0.20
- BLCO -0.01
- Stochastic Oscillator
- FRO 86.69
- BLCO 43.22
About FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.